| Value | ₹5.38 Cr |
|---|---|
| Execution period | Indicative completion date stated as 17-11-2026 |
BSE filing, NSE: ADVENTHTL. Summary written from the filing by ALFA Finder's alert engine.
Advent Hotels International Ltd: key numbers
- Share price
- ₹120.98
- Market cap
- ₹652.6 Cr
- Revenue (annual)
- ₹387.6 Cr
- Net profit (annual)
- ₹63.19 Cr
- P/E (TTM)
- 16.9×Sector 48.0×
- Promoter holding
- 47.69%+0.00% QoQ
- FII holding
- 1.59%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advent Hotels International Ltd
All →Advent Hotels International Merger & Restructuring
Advent Hotels took a 50% stake alongside Prestige Falcon, making Advent Convention a joint venture. The entity is developing a Mumbai commercial project.
Advent Hotels International Q2 FY27 Results: Turns Profitable, Net Profit ₹1.5 Cr
Advent Hotels International Ltd reported revenue from operations of ₹74.1 Cr (-3.8% YoY) and net profit of ₹1.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹1.5 Cr
Advent Hotels International Board Meeting Date
Advent Hotels International Limited has given prior intimation of a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated half-yearly financial results for the period ended September 2026. Trading window closes 01 Oct 2026 to 16 Nov 2026.
Advent Hotels International Other Announcement
Advent Hotels International Ltd has filed its quarterly shareholding pattern under SEBI regulations. This is a periodic compliance disclosure with no material business event.
Advent Hotels International Merger & Restructuring
Advent Hotels International has completed the acquisition of the remaining 25% stake in BD&P Hotels (India), making it a wholly-owned subsidiary.
Advent Hotels International Acquisition Worth ₹40 Cr
Advent Hotels International will acquire the remaining 25% stake in its subsidiary, BD&P Hotels (India), for Rs. 40 Crore, making it a wholly-owned subsidiary.
- Value
- ₹40.00 Cr
Other acquisition announcements
All →Piramal Pharma Acquisition
Piramal Pharma exercised a call option to acquire the remaining 26% stake in subsidiary Yapan Bio. Final consideration and transfer date are yet to be finalised.
Phoenix Mills Acquisition Worth ₹373.9 Cr
Phoenix Mills' stake in subsidiary ISMDPL rose to 71.23% after ISMDPL bought back CPP Investments' shares. Consideration was Rs.373.88 Crore, paid on 18 November 2026.
- Value
- ₹373.9 Cr
AYM Syntex Acquisition
NCLT Mumbai sanctioned the amalgamation of Mandawewala Enterprises into AYM Syntex, effective on sanction. The formal order is awaited and will be disclosed when received.
ACCEL Acquisition Worth ₹3.01 Cr
Accel will buy 2,98,399 Secureinteli shares at ₹101 each, lifting its stake to 84.10%. Secureinteli becomes a subsidiary, a deal worth about ₹3.01 Crore.
- Value
- ₹3.01 Cr
Prestige Estates Projects Acquisition Worth ₹2.69 Cr
Prestige's subsidiary acquired 50% of Advent Convention for ₹2.69 Crore. The target holds 21,978 sq. m land in Mumbai for a ₹4,500 Crore commercial project.
- Value
- ₹2.69 Cr
- leasable area
- 1500000 sq. ft.
Insecticides (India) Acquisition Worth ₹3.54 Cr
Insecticides (India) invested Rs. 3.54 Crore for a 26% stake in FP Alpha Private Limited. The acquisition targets wind and solar captive power capacity in Gujarat.
- Value
- ₹3.54 Cr